Search details
1.
The clinical KRAS(G12C) inhibitor AMG 510 drives anti-tumour immunity.
Nature
; 575(7781): 217-223, 2019 11.
Article
in English
| MEDLINE | ID: mdl-31666701
2.
Common variation in a long non-coding RNA gene modulates variation of circulating TGF-ß2 levels in metastatic colorectal cancer patients (Alliance).
BMC Genomics
; 25(1): 473, 2024 May 14.
Article
in English
| MEDLINE | ID: mdl-38745123
3.
A Pilot Study of Pembrolizumab in Combination With Y90 Radioembolization in Subjects With Poor Prognosis Hepatocellular Carcinoma.
Oncologist
; 29(3): 270-e413, 2024 Mar 04.
Article
in English
| MEDLINE | ID: mdl-38325328
4.
A phase II trial of UGT1A1 genotype-guided FOLFIRI plus bevacizumab as first-line therapy for advanced, unresectable colorectal cancer.
Oncologist
; 2024 Jun 05.
Article
in English
| MEDLINE | ID: mdl-38837045
5.
A multi-center, single-arm, phase Ib study of pembrolizumab (MK-3475) in combination with chemotherapy for patients with advanced colorectal cancer: HCRN GI14-186.
Cancer Immunol Immunother
; 70(11): 3337-3348, 2021 Nov.
Article
in English
| MEDLINE | ID: mdl-34160684
6.
Pembrolizumab for the treatment of programmed death-ligand 1-positive advanced carcinoid or pancreatic neuroendocrine tumors: Results from the KEYNOTE-028 study.
Cancer
; 126(13): 3021-3030, 2020 07 01.
Article
in English
| MEDLINE | ID: mdl-32320048
7.
A phase 1b dose escalation study of Wnt pathway inhibitor vantictumab in combination with nab-paclitaxel and gemcitabine in patients with previously untreated metastatic pancreatic cancer.
Invest New Drugs
; 38(3): 821-830, 2020 06.
Article
in English
| MEDLINE | ID: mdl-31338636
8.
Overall survival of patients with recurrent pancreatic cancer treated with systemic therapy: a retrospective study.
BMC Cancer
; 19(1): 468, 2019 May 17.
Article
in English
| MEDLINE | ID: mdl-31101022
9.
Phase 1 study of EUS-guided photodynamic therapy for locally advanced pancreatic cancer.
Gastrointest Endosc
; 89(2): 390-398, 2019 02.
Article
in English
| MEDLINE | ID: mdl-30222972
10.
Prolonged Response to Anti-PD-1 Antibody Therapy in Chemotherapy-Refractory Cholangiocarcinoma With High Tumor Mutational Burden.
J Natl Compr Canc Netw
; 17(6): 644-648, 2019 06 01.
Article
in English
| MEDLINE | ID: mdl-31200359
11.
CanStem111P trial: a Phase III study of napabucasin plus nab-paclitaxel with gemcitabine.
Future Oncol
; 15(12): 1295-1302, 2019 Apr.
Article
in English
| MEDLINE | ID: mdl-30768369
12.
Social correlates of mental health in gastrointestinal cancer patients and their family caregivers: Exploring the role of loneliness.
Support Care Cancer
; 27(6): 2077-2086, 2019 Jun.
Article
in English
| MEDLINE | ID: mdl-30225573
13.
Phase I/II trial of nano-camptothecin CRLX101 with capecitabine and radiotherapy as neoadjuvant treatment for locally advanced rectal cancer.
Nanomedicine
; 18: 189-195, 2019 06.
Article
in English
| MEDLINE | ID: mdl-30858085
14.
Multicenter, randomized, double-blind phase 2 trial of FOLFIRI with regorafenib or placebo as second-line therapy for metastatic colorectal cancer.
Cancer
; 124(15): 3118-3126, 2018 08 01.
Article
in English
| MEDLINE | ID: mdl-29905927
15.
Examining the effect of peer helping in a coping skills intervention: a randomized controlled trial for advanced gastrointestinal cancer patients and their family caregivers.
Qual Life Res
; 27(2): 515-528, 2018 02.
Article
in English
| MEDLINE | ID: mdl-28601957
16.
A Multidisciplinary Approach to Pancreas Cancer in 2016: A Review.
Am J Gastroenterol
; 112(4): 537-554, 2017 04.
Article
in English
| MEDLINE | ID: mdl-28139655
17.
A phase 1 study combining the HER3 antibody seribantumab (MM-121) and cetuximab with and without irinotecan.
Invest New Drugs
; 35(1): 68-78, 2017 02.
Article
in English
| MEDLINE | ID: mdl-27853996
18.
Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With KRAS Wild-Type Advanced or Metastatic Colorectal Cancer: A Randomized Clinical Trial.
JAMA
; 317(23): 2392-2401, 2017 06 20.
Article
in English
| MEDLINE | ID: mdl-28632865
19.
Sorafenib Effectiveness in Advanced Hepatocellular Carcinoma.
Oncologist
; 21(9): 1113-20, 2016 09.
Article
in English
| MEDLINE | ID: mdl-27185615
20.
Phase II Study of Olaparib (AZD-2281) After Standard Systemic Therapies for Disseminated Colorectal Cancer.
Oncologist
; 21(2): 172-7, 2016 Feb.
Article
in English
| MEDLINE | ID: mdl-26786262